Vaxelis
RxNorm concept 2109616, brand name (bn).
- RxCUI
- 2109616
- Term type
- Brand name (BN)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/2109616 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Ingredients
- poliovirus vaccine inactivated, type 1 (Mahoney) 763096
- poliovirus vaccine inactivated, type 2 (MEF-1) 763098
- poliovirus vaccine inactivated, type 3 (Saukett) 763100
- hepatitis B surface antigen vaccine 797752
- acellular pertussis vaccine, inactivated 798302
- diphtheria toxoid vaccine, inactivated 798304
- tetanus toxoid vaccine, inactivated 798306
- Haemophilus influenzae b (Ross strain) capsular polysaccharide meningococcal protein conjugate vaccine 798444
Related concepts
- Bordetella pertussis filamentous hemagglutinin vaccine, inactivated (PIN, has precise ingredient)
- Bordetella pertussis fimbriae 2/3 vaccine, inactivated (PIN, has precise ingredient)
- Bordetella pertussis pertactin vaccine, inactivated (PIN, has precise ingredient)
- Bordetella pertussis toxoid vaccine, inactivated (PIN, has precise ingredient)
- Bordetella pertussis filamentous hemagglutinin vaccine, inactivated 0.04 MG/ML / Bordetella pertussis fimbriae 2/3 vaccine, inactivated 0.01 MG/ML / Bordetella pertussis pertactin vaccine, inactivated 0.006 MG/ML / Bordetella pertussis toxoid vaccine, inactivated 0.04 MG/ML / diphtheria toxoid vaccine, inactivated 30 UNT/ML / Haemophilus influenzae b (Ross strain) capsular polysaccharide meningococcal protein conjugate vaccine 0.006 MG/ML / hepatitis B surface antigen vaccine 0.02 MG/ML / poliovirus vaccine inactivated, type 1 (Mahoney) 58 UNT/ML / poliovirus vaccine inactivated, type 2 (MEF-1) 14 UNT/ML / poliovirus vaccine inactivated, type 3 (Saukett) 52 UNT/ML / tetanus toxoid vaccine, inactivated 10 UNT/ML [Vaxelis] (SBDC, ingredient of)
- acellular pertussis vaccine, inactivated / diphtheria toxoid vaccine, inactivated / Haemophilus influenzae b (Ross strain) capsular polysaccharide meningococcal protein conjugate vaccine / hepatitis B surface antigen vaccine / poliovirus vaccine inactivated, type 1 (Mahoney) / poliovirus vaccine inactivated, type 2 (MEF-1) / poliovirus vaccine inactivated, type 3 (Saukett) / tetanus toxoid vaccine, inactivated Injection [Vaxelis] (SBDF, ingredient of)
- Vaxelis Injectable Product (SBDG, ingredient of)
- 0.5 ML Bordetella pertussis filamentous hemagglutinin vaccine, inactivated 0.04 MG/ML / Bordetella pertussis fimbriae 2/3 vaccine, inactivated 0.01 MG/ML / Bordetella pertussis pertactin vaccine, inactivated 0.006 MG/ML / Bordetella pertussis toxoid vaccine, inactivated 0.04 MG/ML / diphtheria toxoid vaccine, inactivated 30 UNT/ML / Haemophilus influenzae b (Ross strain) capsular polysaccharide meningococcal protein conjugate vaccine 0.006 MG/ML / hepatitis B surface antigen vaccine 0.02 MG/ML / poliovirus vaccine inactivated, type 1 (Mahoney) 58 UNT/ML / poliovirus vaccine inactivated, type 2 (MEF-1) 14 UNT/ML / poliovirus vaccine inactivated, type 3 (Saukett) 52 UNT/ML / tetanus toxoid vaccine, inactivated 10 UNT/ML Injection [Vaxelis] (SBD, ingredient of)
- acellular pertussis vaccine, inactivated / diphtheria toxoid vaccine, inactivated / Haemophilus influenzae b (Ross strain) capsular polysaccharide meningococcal protein conjugate vaccine / hepatitis B surface antigen vaccine / poliovirus vaccine inactivated, type 1 (Mahoney) / poliovirus vaccine inactivated, type 2 (MEF-1) / poliovirus vaccine inactivated, type 3 (Saukett) / tetanus toxoid vaccine, inactivated Prefilled Syringe [Vaxelis] (SBDF, ingredient of)
- 0.5 ML Bordetella pertussis filamentous hemagglutinin vaccine, inactivated 0.04 MG/ML / Bordetella pertussis fimbriae 2/3 vaccine, inactivated 0.01 MG/ML / Bordetella pertussis pertactin vaccine, inactivated 0.006 MG/ML / Bordetella pertussis toxoid vaccine, inactivated 0.04 MG/ML / diphtheria toxoid vaccine, inactivated 30 UNT/ML / Haemophilus influenzae b (Ross strain) capsular polysaccharide meningococcal protein conjugate vaccine 0.006 MG/ML / hepatitis B surface antigen vaccine 0.02 MG/ML / poliovirus vaccine inactivated, type 1 (Mahoney) 58 UNT/ML / poliovirus vaccine inactivated, type 2 (MEF-1) 14 UNT/ML / poliovirus vaccine inactivated, type 3 (Saukett) 52 UNT/ML / tetanus toxoid vaccine, inactivated 10 UNT/ML Prefilled Syringe [Vaxelis] (SBD, ingredient of)
- poliovirus vaccine inactivated, type 1 (Mahoney) (IN, tradename of)
- poliovirus vaccine inactivated, type 2 (MEF-1) (IN, tradename of)
- poliovirus vaccine inactivated, type 3 (Saukett) (IN, tradename of)
- hepatitis B surface antigen vaccine (IN, tradename of)
- acellular pertussis vaccine, inactivated (IN, tradename of)
- diphtheria toxoid vaccine, inactivated (IN, tradename of)
- tetanus toxoid vaccine, inactivated (IN, tradename of)
- Haemophilus influenzae b (Ross strain) capsular polysaccharide meningococcal protein conjugate vaccine (IN, tradename of)
Linked data
NDCs
RxNorm links no NDCs to this concept.
Use it
Look up 2109616 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/2109616 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 2109616. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.